Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients

Clinical and Experimental Nephrology

Volumn 18, Issue 6, 2014, Pages 892-898

  Gao, Yu mei ^a   Li, Di ^a   Cheng, Hong ^a   Chen, Yi pu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Contrast media; Coronary artery; Risk score

Indexed keywords

CONTRAST MEDIUM; CREATININE; IODIXANOL; IOHEXOL; IOPROMIDE;

ACUTE HEART INFARCTION; ADULT; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; ASSESSMENT OF HUMANS; CALIBRATION; CHINESE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART FAILURE; HOSMER LEMESHOW GOODNESS OF FIT TEST; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; VALIDATION PROCESS; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AGED; BLOOD; CHEMICALLY INDUCED; CHINA; COMPARATIVE STUDY; HEALTH STATUS INDICATOR; MIDDLE AGED; RANDOMIZATION; STATISTICAL MODEL; VALIDATION STUDY;

ACUTE KIDNEY INJURY; AGED; CARDIAC CATHETERIZATION; CHINA; COHORT STUDIES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84919839535     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-0942-9     Document Type: Article

References (30)

1. Erselcan T, Egilmez H, Hasbek Z, et al. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients. Acta Radiol. 2012;53:228–32.
2. Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. 2010;25:191–204.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–6.
4. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.
5. Lakhal K, Ehrmann S, Chaari A, et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26:593–9.
6. Li D, Gao Y, Cheng H, et al. Comparative study of diagnosis for contrast-induced nephropathy by ESUR and modified ESUR definitions. Chin J Pract Intern Med. 2011;31:938–40.
7. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.
8. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.
9. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.
10. Bouzas-Mosquera A, Vazquez-Rodriguez JM, Calvino-Santos R, et al. Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis. Rev Esp Cardiol. 2007;60:1026–34.
11. Maioli M, Toso A, Gallopin M, et al. Preprocedural score for risk of contrast- induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med (Hagerstown). 2010;11:444–9.
12. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–9.
13. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–41.
14. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol. 2009;22:333–51.
15. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20:672–9.
16. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9:1602–13.
17. Budano C, Levis M, D’Amico M, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J. 2011;161:963–71.
18. Jabara R, Gadesam RR, Pendyala LK, et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol. 2009;103:1657–62.
19. Toprak O. What is the best definition of contrast-induced nephropathy? Ren Fail. 2007;29:387–8.
20. Mccullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K–36K.
21. Musso CG, Liakopoulos V, Ioannidis I, et al. Acute renal failure in the elderly: particular characteristics. Int Urol Nephrol. 2006;38:787–93.
22. Abdel-Kader K, Palevsky PM. Acute kidney injury in the elderly. Clin Geriatr Med. 2009;25:331–58.
23. Conen D, Buerkle G, Perruchoud AP, et al. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int J Cardiol. 2006;110:237–41.
24. Toprak O. Risk markers for contrast-induced nephropathy. Am J Med Sci. 2007;334:283–90.
25. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–5.
26. Brown JR, DeVries JT, Piper WD, et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J. 2008;155:260–6.
27. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–9.
28. Tziakas D, Chalikias G, Stacos D, et al. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013;163:46–55.
29. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3:491–8.
30. Aykan AC, Gul I, Gokdeniz T, et al. Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention? Heart Lung Circ. 2013;. doi:10.1016/j.hlc.2013.03.085.